Publicacions en col·laboració amb investigadors/es de Hospital Universitario de Getafe (12)

2022

  1. IL-15/IL-15Rα in SJS/TEN: Relevant Expression of IL15 and IL15RA in Affected Skin

    Biomedicines, Vol. 10, Núm. 8

2021

  1. Relationship between influenza, temperature, and type 1 myocardial infarction: An ecological time-series study

    Journal of the American Heart Association, Vol. 10, Núm. 8

2020

  1. Assessment of drug causality in Stevens-Johnson syndrome/toxic epidermal necrolysis: Concordance between lymphocyte transformation test and ALDEN

    Allergy: European Journal of Allergy and Clinical Immunology

  2. Heat waves, ambient temperature, and risk of myocardial infarction: an ecological study in the Community of Madrid

    Revista Espanola de Cardiologia, Vol. 73, Núm. 4, pp. 300-306

  3. Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study

    The Lancet, Vol. 395, Núm. 10238, pp. 1705-1714

2019

  1. Incidence of Stevens-Johnson syndrome/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study

    European Journal of Clinical Pharmacology, Vol. 75, Núm. 2, pp. 237-246

2018

  1. Active surveillance of severe cutaneous adverse reactions: A case-population approach using a registry and a health care database

    Pharmacoepidemiology and Drug Safety, Vol. 27, Núm. 9, pp. 1042-1050

  2. Care in patients with epidermal necrolysis in burn units. A nursing perspective

    Burns, Vol. 44, Núm. 8, pp. 1962-1972

2017

  1. Approach to Severe Cutaneous Adverse Drug Reactions

    Current Treatment Options in Allergy, Vol. 4, Núm. 2, pp. 201-221

  2. Cyclosporine Use in Epidermal Necrolysis Is Associated with an Important Mortality Reduction: Evidence from Three Different Approaches

    Journal of Investigative Dermatology, Vol. 137, Núm. 10, pp. 2092-2100

2016

  1. The HLA-B∗15:02 allele in a Spanish Romani patient with carbamazepine-induced Stevens-Johnson syndrome

    Pharmacogenomics, Vol. 17, Núm. 6, pp. 541-545

  2. Vemurafenib-induced toxic epidermal necrolysis: Possible cross-reactivity with other sulfonamide compounds

    British Journal of Dermatology, Vol. 174, Núm. 3, pp. 621-624